Translation, transcultural adaptation, and validation of the Serbian version of the PSS-QoL questionnaire – a pilot research

Sanja Vujović; Jana Desnica; Sara Mijailović; Dragan Milovanović

doi:10.2298/VSP220518080V

Sanja Vujović University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
Jana Desnica University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
Sara Mijailović University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia
Dragan Milovanović University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia

DOI: https://doi.org/10.2298/VSP220518080V

Keywords: quality of life, serbia, sjogren’s syndrome, surveys and questionnaires, translations

Abstract

Background/Aim. The assessment of health-related quality of life (HRQoL) is fundamental for a better understanding of the effect of a disease on different aspects of a patient’s daily functioning and the efficacy of the treatment modalities. Primary Sjögren’s Syndrome (SS) Quality of Life Questionnaire (PSS-QoL) is the first disease-specific instrument for evaluating HRQoL in patients with primary SS. The aim of this study was to formally translate the PSS-QoL questionnaire from English to Serbian, assess its psychometric properties, and validate it for use in the Serbian population. Methods. The research was designed as a pilot study and included 30 participants. Internal consistency was determined by calculating Cronbach’s alpha coefficient. The construct validity of the questionnaire was estimated by the correlation of its overall result with the patients’ EuroQoL-5D, European League Against Rheumatism (EULAR) SS Patient Reported Index, Oral Health Impact Profile-14, and Emotion Regulation Questionnaire scores. Results. There were 29 (96.7%) female participants and one (3.3%) male participant in the research. The average (± standard deviation) score of PSS-QoL was 44.63 ± 12.901 at baseline and 41.70 ± 12.075 at follow-up. Cronbach’s alpha value of the Serbian version of PSS-QoL was 0.922. The test-retest intraclass correlation coefficient was 0.981 (95% confidence interval: 0.436–0.996). Analysis revealed a statistically significant moderate to strong correlation between PSS-QoL scores and EuroQol-5D (r_s= -0.696), EULAR SS Patient Reported Index (r_s= 0.883), and Oral Health Impact Profile-14 scores (r_s= 0.809). Conclusion. Serbian adaptation of the PSS-QoL instrument can be used to evaluate HRQoL of patients with primary SS both in academic research and clinical practice as a novel outcome measure.

Author Biography

Sanja Vujović, University of Kragujevac, Faculty of Medical Sciences, Kragujevac, Serbia

Background/Aim. The assessment of health-related quality of life (HRQoL) is fundamental for a better understanding of the effect of a disease on different aspects of a patient’s daily functioning and the efficacy of the treatment modalities. Primary Sjögren’s Syndrome (SS) Quality of Life Questionnaire (PSS-QoL) is the first disease-specific instrument for evaluating HRQoL in patients with primary SS. The aim of this study was to formally translate the PSS-QoL questionnaire from English to Serbian, assess its psychometric properties, and validate it for use in the Serbian population. Methods. The research was designed as a pilot study and included 30 participants. Internal consistency was determined by calculating Cronbach’s alpha coefficient. The construct validity of the questionnaire was estimated by the correlation of its overall result with the patients’ EuroQoL-5D, European League Against Rheumatism (EULAR) SS Patient Reported Index, Oral Health Impact Profile-14, and Emotion Regulation Questionnaire scores. Results. There were 29 (96.7%) female participants and one (3.3%) male participant in the research. The average (± standard deviation) score of PSS-QoL was 44.63 ± 12.901 at baseline and 41.70 ± 12.075 at follow-up. Cronbach’s alpha value of the Serbian version of PSS-QoL was 0.922. The test-retest intraclass correlation coefficient was 0.981 (95% confidence interval: 0.436–0.996). Analysis revealed a statistically significant moderate to strong correlation between PSS-QoL scores and EuroQol-5D (r_s= -0.696), EULAR SS Patient Reported Index (r_s= 0.883), and Oral Health Impact Profile-14 scores (r_s= 0.809). Conclusion. Serbian adaptation of the PSS-QoL instrument can be used to evaluate HRQoL of patients with primary SS both in academic research and clinical practice as a novel outcome measure.

References

1. Vitali C, Minniti A, Pignataro F, Maglione W, Del Papa N. Management of Sjögren's syndrome: present issues and future perspectives. Front Med (Lausanne) 2021; 8: 676885.

2. Patel R, Shahane A. The epidemiology of Sjögren's syndrome. Clin Epidemiol 2014; 6: 247‒55.

3. Vitali C, Del Papa N. Pain in primary Sjögren's syndrome. Best Pract Res Clin Rheumatol 2015; 29(1): 63‒70.

4. Peredo RA, Beegle S. Sjogren's syndrome and pulmonary disease. Adv Exp Med Biol 2021; 1303: 193‒207.

5. Retamozo S, Acar-Denizli N, Rasmussen A, Horváth IF, Baldini C, Priori R, et al. Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. Clin Exp Rheumatol 2019; 118(3): 97‒106.

6. Koçer B, Tezcan ME, Batur HZ, Haznedaroğlu Ş, Göker B, İrkeç C, et al. Cognition, depression, fatigue, and quality of life in primary Sjögren's syndrome: correlations. Brain Behav 2016; 6(12): e00586.

7. Miyamoto ST, Valim V, Fisher BA. Health-related quality of life and costs in Sjögren's syndrome. Rheumatology (Oxford) 2019; key370.

8. Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res 2019; 28(10): 2641‒50.

9. Lackner A, Stradner MH, Hermann J, Unger J, Stamm T, Graninger WB, et al. Assessing health-related quality of life in primary Sjögren's syndrome-the PSS-QoL. Semin Arthritis Rheum 2018; 48(1): 105‒10.

10. Chou A, Gonzales JA, Daniels TE, Criswell LA, Shiboski SC, Shiboski CH. Health-related quality of life and depression among participants in the Sjögren's International Collaborative Clinical Alliance registry. RMD Open 2017; 3(2): e000495.

11. Dias LH, Miyamoto ST, Giovelli RA, de Magalhães CIM, Valim V. Pain and fatigue are predictors of quality of life in primary Sjögren's syndrome. Adv Rheumatol 2021; 61(1): 28.

12. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for Patient-Reported Outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005; 8(2): 94‒104.

13. Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ 2018; 27(1): 7‒22.

14. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. Ann Rheum Dis 2011; 70(6): 968‒72.

15. Paganotti MA, Valim V, Serrano ÉV, Miyamoto ST, Giovelli RA, Santos MC. Validation and psychometric properties of the Eular Sjögren's Syndrome Patient Reported Index (ESSPRI) into Brazilian Portuguese. Rev Bras Reumatol 2015; 55(5): 439‒45. (English, Portuguese)

16. Campos LA, Peltomäki T, Marôco J, Campos JADB. Use of Oral Health Impact Profile-14 (OHIP-14) in Different Contexts. What Is Being Measured? Int J Environ Res Public Health 2021; 18(24): 13412.

17. Gross JJ, John OP. Individual differences in two emotion regulation processes: Implications for affect, relationships, and well-being. J Pers Soc Psychol 2003; 85(2): 348‒62.

18. Popov S, Janičić B, Dinić B. Validation of the Serbian adaptation of the Emotion regulation questionnaire (ERQ). Primenj Psihol 2016; 9(1): 63–81.

19. Janković S, Bogavac-Stanojević N, Mikulić I, Izetbegović S, Iličković I, Krajnović D, et al. A questionnaire for rating health-related quality of life. Zdr Varst 2021; 60(4): 260‒8.

20. de Jong Z, van der Heijde D, McKenna SP, Whalley D. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 1997; 36(8): 878‒83.

21. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62(1): 20‒6.

22. Fernández-Martínez G, Zamora-Legoff V, Hernández Molina G. Oral health-related quality of life in primary Sjögren's syndrome. Reumatol Clin (Engl Ed) 2020; 16(2 Pt 1): 92‒6. (English, Spanish)

23. Azuma N, Katada Y, Yoshikawa T, Yokoyama Y, Nishioka A, Sekiguchi M, et al. Evaluation of changes in oral health-related quality of life over time in patients with Sjögren's syndrome. Mod Rheumatol 2021; 31(3): 669‒77.